| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| John J Alam, Paul Maruff, Susan Doctrow, Hui-May Chu, Jennifer Conway, Stephen N Gomperts, Charlotte Teunisse. Association of Plasma Phosphorylated Tau With the Response to Neflamapimod Treatment in Patients With Dementia With Lewy Bodies. Neurology. 2023-09-01. PMID:37657939. |
in a proportion of patients, dementia with lewy bodies (dlb) is associated with alzheimer's disease (ad) co-pathology, which is linked to accelerated cognitive decline and more extensive cortical atrophy. |
2023-09-01 |
2023-09-07 |
Not clear |
| Olivier Bousiges, Benjamin Cretin, Candice Muller, Anne Botzung, Lea Sanna, Pierre Anthony, Nathalie Philippi, Catherine Demuynck, Frédéric Blan. Involvement of ApoE4 in dementia with Lewy bodies in the prodromal and demented stages: evaluation of the Strasbourg cohort. GeroScience. 2023-08-31. PMID:37653269. |
in this cohort, 197 patients were genotyped: 105 dlb patients, 37 alzheimer's disease (ad) patients, 29 patients with ad/dlb comorbidity, and 26 control subjects (cs). |
2023-08-31 |
2023-09-07 |
human |
| Asmus Vogel, Clara Mellergaard, Kristian Steen Frederikse. Different language profiles on neuropsychological tests in dementia with Lewy bodies and Alzheimer's disease. Applied neuropsychology. Adult. 2023-08-18. PMID:37595289. |
dementia with lewy bodies (dlb) and alzheimer's disease (ad) may lead to different cognitive profiles. |
2023-08-18 |
2023-10-07 |
Not clear |
| Noah J Graves, Yann Gambin, Emma Siereck. α-Synuclein Strains and Their Relevance to Parkinson's Disease, Multiple System Atrophy, and Dementia with Lewy Bodies. International journal of molecular sciences. vol 24. issue 15. 2023-08-12. PMID:37569510. |
in addition to pd, αsyn pathological aggregation is also detected in atypical parkinsonism, including dementia with lewy bodies (dlb), multiple system atrophy (msa), as well as neurodegeneration with brain iron accumulation, some cases of traumatic brain injuries, and variants of alzheimer's disease. |
2023-08-12 |
2023-08-16 |
Not clear |
| Ji-Yun Cheng, Yue-Ting Deng, Jin-Tai Y. The causal role of circulating amino acids on neurodegenerative disorders: A two-sample Mendelian randomization study. Journal of neurochemistry. 2023-08-11. PMID:37565992. |
the potential causalities between nine amino acids (glutamine [glu], leucine [leu], isoleucine [ile], phenylalanine [phe], valine [val], alanine [ala], tyrosine [tyr], histidine [his], and glycine [gly]) and six neurodegenerative disorders (alzheimer's disease [ad], parkinson's disease [pd], multiple sclerosis [ms], frontotemporal dementia [ftd], lewy body dementia [dlb], amyotrophic lateral sclerosis [als]) were explored in this study. |
2023-08-11 |
2023-08-16 |
Not clear |
| Magdalena I Tolea, Reem Ezzeddine, Simone Camacho, James E Galvi. Emerging drugs for dementia with Lewy bodies: A review of Phase II & III trials. Expert opinion on emerging drugs. 2023-08-02. PMID:37531299. |
despite faster cognitive decline and greater negative impact on patients and family caregivers, drug development efforts in dementia with lewy bodies (dlb) fall behind those for alzheimer's disease (ad). |
2023-08-02 |
2023-08-14 |
Not clear |
| Yanaika S Hok-A-Hin, Katharina Bolsewig, Daimy N Ruiters, Alberto Lleó, Daniel Alcolea, Afina W Lemstra, Wiesje M van der Flier, Charlotte E Teunissen, Marta Del Camp. Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross-platform validation study. Alzheimer's & dementia (Amsterdam, Netherlands). vol 15. issue 3. 2023-07-28. PMID:37502019. |
our previous antibody-based cerebrospinal fluid (csf) proteomics study showed that thimet oligopeptidase (thop1), an amyloid beta (aβ) neuropeptidase, was increased in mild cognitive impairment with amyloid pathology (mci-aβ+) and alzheimer's disease (ad) dementia compared with controls and dementia with lewy bodies (dlb), highlighting the potential of csf thop1 as an early specific biomarker for ad. |
2023-07-28 |
2023-08-14 |
Not clear |
| Yueyi Yu, Xinyi Xia, Xiaosheng Meng, Dan Li, Qi Qi. Plasma Phosphorylated Tau181 and Amyloid-β42 in Dementia with Lewy Bodies Compared with Alzheimer's Disease and Cognitively Healthy People. Journal of Alzheimer's disease : JAD. 2023-07-24. PMID:37482995. |
increasing evidence illustrates the value of plasma biomarkers of alzheimer's disease (ad) to screen for and identify dementia with lewy bodies (dlb). |
2023-07-24 |
2023-08-14 |
Not clear |
| Adam L Piccolino, Ava R Piccolino, Sophia G Piccolin. Distinguishing Alzheimer's disease from other dementias using pattern profile analysis in the Meyers Neuropsychological Battery: An exploratory study. Applied neuropsychology. Adult. 2023-07-21. PMID:37477644. |
it compared neuropsychological test data profiles of alzheimer's disease (ad) patients from three independent samples against four mnb dementia groups: mnb-ad, mnb-vascular dementia (vad), mnb-dementia with lewy bodies (dlb), and mnb-parkinson's disease dementia (pdd). |
2023-07-21 |
2023-08-14 |
Not clear |
| Joyce R Chong, Yuek Ling Chai, Huayang Xing, Deron R Herr, Markus R Wenk, Paul T Francis, Clive Ballard, Dag Aarsland, David L Silver, Christopher P Chen, Amaury Cazenave-Gassiot, Mitchell K P La. Decreased DHA-containing phospholipids in the neocortex of dementia with Lewy bodies are associated with soluble Aβ Brain pathology (Zurich, Switzerland). 2023-07-18. PMID:37463072. |
while alterations of specific dha-containing phospholipids have been described in the neocortex of patients with alzheimer's disease (ad), the status of these lipids in dementia with lewy bodies (dlb), known to manifest aggregated α-synuclein-containing lewy bodies together with variable amyloid pathology, is unclear. |
2023-07-18 |
2023-08-14 |
Not clear |
| Sungwoo Kang, So Hoon Yoon, Han Kyu Na, Young-Gun Lee, Seun Jeon, Kyoungwon Baik, Young H Sohn, Byoung Seok Y. Neuropsychological Comparison of Patients With Alzheimer's Disease and Dementia With Lewy Bodies. Journal of clinical neurology (Seoul, Korea). 2023-07-17. PMID:37455503. |
this study aimed to determine the neuropsychological differences between patients with early-stage alzheimer's disease (ad) and dementia with lewy bodies (dlb) with a clinical dementia rating (cdr) score of ≤1. |
2023-07-17 |
2023-08-14 |
Not clear |
| Manuel Flores-Leon, Tiago Fleming Outeir. More than meets the eye in Parkinson's disease and other synucleinopathies: from proteinopathy to lipidopathy. Acta neuropathologica. 2023-07-08. PMID:37421475. |
the accumulation of proteinaceous inclusions in the brain is a common feature among neurodegenerative diseases such as alzheimer's disease, parkinson's disease (pd), and dementia with lewy bodies (dlb). |
2023-07-08 |
2023-08-14 |
Not clear |
| Parichita Choudhury, Nan Zhang, Charles H Adler, Kewei Chen, Christine Belden, Erika Driver-Dunckley, Shyamal H Mehta, David R Shprecher, Geidy E Serrano, Holly A Shill, Thomas G Beach, Alireza Atr. Longitudinal motor decline in dementia with Lewy bodies, Parkinson disease dementia, and Alzheimer's dementia in a community autopsy cohort. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2023-07-08. PMID:37422286. |
we examined the progression of extrapyramidal symptoms and signs in autopsy-confirmed dementia with lewy bodies (dlb), parkinson's disease dementia (pdd), and alzheimer's disease dementia (ad). |
2023-07-08 |
2023-08-14 |
Not clear |
| Young-Gun Lee, Seun Jeon, Sung Woo Kang, Byoung Seok Y. Effects of amyloid beta and dopaminergic depletion on perfusion and clinical symptoms. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2023-07-08. PMID:37422287. |
although mixed pathologies are common in alzheimer's disease (ad) and dementia with lewy bodies (dlb), the effects of amyloid beta and dopaminergic depletion on brain perfusion and clinical symptoms have not been elucidated. |
2023-07-08 |
2023-08-14 |
Not clear |
| Kurt A Jellinge. Depression in dementia with Lewy bodies: a critical update. Journal of neural transmission (Vienna, Austria : 1996). 2023-07-07. PMID:37418037. |
there are no essential differences in the frequency of depression in dlb and parkinson disease-dementia (pdd), while its severity is up to twice as high as in alzheimer disease (ad). |
2023-07-07 |
2023-08-14 |
Not clear |
| Kurt A Jellinge. Depression in dementia with Lewy bodies: a critical update. Journal of neural transmission (Vienna, Austria : 1996). 2023-07-07. PMID:37418037. |
since compared to depression in other dementias like alzheimer disease and other parkinsonian syndromes, our knowledge of its molecular basis is limited, and further studies to elucidate the heterogeneous pathogenesis of depression in dlb are warranted. |
2023-07-07 |
2023-08-14 |
Not clear |
| Kurt A Jellinge. Mild cognitive impairment in dementia with Lewy bodies: an update and outlook. Journal of neural transmission (Vienna, Austria : 1996). 2023-07-07. PMID:37418039. |
dementia with lewy bodies (dlb), the second most common degenerative neurocognitive disorder after alzheimer disease (ad), is frequently preceded by a period of mild cognitive impairment (mci), in which cognitive decline is associated with impairment of executive functions/attention, visuospatial deficits, or other cognitive domains and a variety of noncognitive and neuropsychiatric symptoms, many of which are similar but less severe than in prodromal ad. |
2023-07-07 |
2023-08-14 |
Not clear |
| Katherine Fodder, Rohan de Silva, Thomas T Warner, Conceição Bettencour. The contribution of DNA methylation to the (dys)function of oligodendroglia in neurodegeneration. Acta neuropathologica communications. vol 11. issue 1. 2023-06-29. PMID:37386505. |
however, a central feature consists of regional aggregation of proteins in the brain, such as the accumulation of β-amyloid plaques in alzheimer's disease (ad), inclusions of hyperphosphorylated microtubule-binding tau in ad and other tauopathies, or inclusions containing α-synuclein in parkinson's disease (pd), dementia with lewy bodies (dlb) and multiple system atrophy (msa). |
2023-06-29 |
2023-08-14 |
Not clear |
| Kurt A Jellinge. Morphological characteristics differentiate dementia with Lewy bodies from Parkinson disease with and without dementia. Journal of neural transmission (Vienna, Austria : 1996). 2023-06-12. PMID:37306790. |
clinically distinguished by the temporal sequence of motor and cognitive symptoms, the pathology of pdd and dlb includes variable combinations of lewy body (lb) and alzheimer (ad) lesions, both being more severe in dlb, but much less frequent and less severe in pdnd. |
2023-06-12 |
2023-08-14 |
Not clear |
| János Bencze, Woosung Seo, Abdul Hye, Dag Aarsland, Tibor Hortobágy. Dementia with Lewy bodies - a clinicopathological update. Free neuropathology. vol 1. 2023-06-07. PMID:37283665. |
although alzheimer's disease (ad), as the most frequent neurodegenerative dementia, has been extensively analysed, less is known about dementia with lewy bodies (dlb). |
2023-06-07 |
2023-08-14 |
Not clear |